SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/BD8993F9C3525C16564CC8F7E96340643FD54E39AA9C3733134B95EEBE406D02D77554A857B8D6A3CC064543CF1633DF>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/BD8993F9C3525C16564CC8F7E96340643FD54E39AA9C3733134B95EEBE406D02D77554A857B8D6A3CC064543CF1633DF
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/BD8993F9C3525C16564CC8F7E96340643FD54E39AA9C3733134B95EEBE406D02D77554A857B8D6A3CC064543CF1633DF
http://www.w3.org/2000/01/rdf-schema#comment
"Overcoming resistance to immune checkpoint therapy in PTEN-null prostate cancer by intermittent anti-PI3Kalpha/beta/delta treatment."
xsd:string
http://purl.uniprot.org/uniprot/#_8AECD68ECE77B23C999E480AC9BD23B07EE350C3D6092BEBBB29572C76117287B606BB8942AFA889DE0C3F1DBDF5C509
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/BD8993F9C3525C16564CC8F7E96340643FD54E39AA9C3733134B95EEBE406D02D77554A857B8D6A3CC064543CF1633DF
http://purl.uniprot.org/uniprot/P42337
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/BD8993F9C3525C16564CC8F7E96340643FD54E39AA9C3733134B95EEBE406D02D77554A857B8D6A3CC064543CF1633DF
http://purl.uniprot.org/uniprot/#_P42337-mappedCitation-35013322
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/BD8993F9C3525C16564CC8F7E96340643FD54E39AA9C3733134B95EEBE406D02D77554A857B8D6A3CC064543CF1633DF